Lansoprazol Cinfamed

Lansoprazole, the active ingredient in Lansoprazol Cinfamed, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, Helicobacter pylori eradication regimens, and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Lansoprazol Cinfamed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers.

Lansoprazol Cinfamed is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): Decreases gastric acid, relieving heartburn and esophageal irritation. - Peptic ulcer disease: Promotes ulcer healing by reducing acid secretion. - Helicobacter pylori eradication regimens: Enhances effectiveness of antibiotic therapy by suppressing gastric acid. - Zollinger‑Ellison syndrome: Controls excessive gastric acid production associated with gastrin‑secreting tumors.

Lansoprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, usually self‑limiting. - Nausea: feeling of sickness. - Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis with watery diarrhea. - Acute interstitial nephritis: kidney inflammation presenting with rash and fever. - Hypomagnesemia: low serum magnesium causing muscle cramps or arrhythmias.

Before initiating Lansoprazol Cinfamed, consider the following precautions to ensure safe use.

- Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate for osteoporosis risk: long‑term use may affect calcium absorption. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for gastrointestinal infections: especially with prolonged therapy. - Store at room temperature: keep in the original container, protect from moisture.

Lansoprazole can alter the pharmacokinetics of several medicines; awareness of key interactions is essential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity. - Atazanavir: decreased antiviral absorption.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Digoxin: increased serum levels, monitor for toxicity. - Methotrexate: higher exposure, especially with high doses. - Phenytoin: reduced seizure control, monitor levels.